Clinical trial
Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin
NCT02197078 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 30, 2014
- Completion date
- February 26, 2019
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.